Stay updated on Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial
Sign up to get notified when there's something new on the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page.

Latest updates to the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page
- Check2 days agoChange DetectedA notice about NIH’s terminology transition was added above the 403 error page. The site revision label changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site release as v3.7.1.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study content. This indicates the page is blocked due to permission restrictions, preventing viewing the study details.SummaryDifference0.5%

- Check30 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, blocking access to the NCT01636206 content. The UI presents a generic error page with standard navigation and footer instead of the study information.SummaryDifference17%

- Check37 days agoChange DetectedRevision: v3.7.0 appears instead of v3.6.6, indicating a backend or template update behind the page rather than a change in study content.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision stamp was updated to v3.6.6, indicating a minor internal update to the page version without altering study details.SummaryDifference0.1%

Stay in the know with updates to Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Study of Lifitegrast to Treat Dry Eye Clinical Trial page.